US Stock MarketDetailed Quotes

LXRX Lexicon Pharmaceuticals

Watchlist
  • 0.392
  • +0.024+6.55%
Close Mar 7 16:00 ET
  • 0.378
  • -0.014-3.50%
Post 20:01 ET
141.63MMarket Cap-0.62P/E (TTM)

Lexicon Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-10.43%-178.78M
57.48%-21.49M
-28.83%-53.62M
-27.34%-48.54M
-74.39%-55.13M
-82.21%-161.9M
-134.35%-50.55M
-114.10%-41.62M
-56.08%-38.12M
-34.98%-31.61M
Net income from continuing operations
-13.15%-200.4M
32.14%-33.77M
-28.28%-64.81M
-18.98%-53.43M
-51.55%-48.4M
-73.74%-177.12M
-63.17%-49.76M
-116.04%-50.53M
-82.63%-44.9M
-36.03%-31.93M
Depreciation and amortization
-3.61%534K
-14.97%125K
-16.56%126K
-3.47%139K
28.57%144K
29.74%554K
42.72%147K
39.81%151K
34.58%144K
2.75%112K
Other non cash items
-19.14%2.66M
-65.63%732K
869.74%5.99M
-1,696.70%-4.36M
9.81%291K
343.45%3.29M
517.39%2.13M
184.79%618K
77.27%273K
960.00%265K
Change In working capital
435.46%14.24M
375.15%11.77M
23.41%9.69M
66.34%4.25M
-230.45%-11.47M
561.44%2.66M
-182.16%-4.28M
705.33%7.85M
187.26%2.56M
-21.75%-3.47M
-Change in receivables
-150.81%-2.46M
16.47%-578K
-174.93%-275K
-158.63%-1.09M
-120.51%-516K
-6,914.29%-982K
-5,866.67%-692K
6,216.67%367K
-14,200.00%-423K
-917.39%-234K
-Change in inventory
139.37%150K
1,000.00%405K
68.90%-51K
58.72%-71K
---133K
---381K
---45K
---164K
---172K
--0
-Change in prepaid assets
120.63%598K
325.52%2.17M
-43.27%969K
76.01%-666K
-116.72%-1.88M
-817.41%-2.9M
-725.97%-964K
551.91%1.71M
-176.22%-2.78M
-417.58%-867K
-Change in payables and accrued expense
129.33%14.8M
443.93%9.13M
45.12%8.87M
2.52%5.91M
-228.81%-9.11M
8,392.11%6.45M
-156.31%-2.65M
654.69%6.11M
369.52%5.77M
16.26%-2.77M
-Change in other current assets
146.68%1.15M
719.23%639K
202.33%176K
6.21%171K
-58.50%166K
-28.81%467K
-76.15%78K
-89.01%-172K
-24.41%161K
93.24%400K
Cash from discontinued investing activities
Operating cash flow
-10.43%-178.78M
57.48%-21.49M
-28.83%-53.62M
-27.34%-48.54M
-74.39%-55.13M
-82.21%-161.9M
-134.35%-50.55M
-114.10%-41.62M
-56.08%-38.12M
-34.98%-31.61M
Investing cash flow
Cash flow from continuing investing activities
69.21%-15.38M
3.47%53.7M
235.96%53.47M
83.48%-12.32M
-1,011.47%-110.22M
29.73%-49.94M
114.69%51.9M
49.06%-39.33M
-446.66%-74.61M
374.34%12.09M
Net PPE purchase and sale
-119.36%-1.03M
---474K
-269.88%-307K
-79.86%-250K
--0
64.56%-470K
--0
-1,975.00%-83K
---139K
-226.32%-248K
Net investment purchase and sale
71.00%-14.35M
4.39%54.17M
237.03%53.78M
83.79%-12.07M
-993.15%-110.22M
29.07%-49.47M
104.16%51.9M
49.16%-39.24M
-445.64%-74.47M
384.88%12.34M
Cash from discontinued investing activities
Investing cash flow
69.21%-15.38M
3.47%53.7M
235.96%53.47M
83.48%-12.32M
-1,011.47%-110.22M
29.73%-49.94M
114.69%51.9M
49.06%-39.33M
-446.66%-74.61M
374.34%12.09M
Financing cash flow
Cash flow from continuing financing activities
26.81%238.35M
-10,300.00%-104K
-336.19%-916K
-100.01%-14K
29,151.33%239.38M
32.17%187.96M
-100.00%-1K
-100.22%-210K
189M
-103.54%-824K
Net issuance payments of debt
--0
--0
--0
----
----
2.24%49.96M
-100.00%-1K
100.40%1K
----
----
Net common stock issuance
-101.25%-1.73M
---89K
--0
-100.00%1K
-99.27%-1.64M
47.84%138M
--0
-100.22%-211K
--139.03M
4.63%-824K
Net preferred stock issuance
--241.32M
---78K
---10K
---15K
--241.43M
--0
--0
--0
--0
--0
Proceeds from stock option exercised by employees
--64K
----
----
----
----
--0
----
----
----
----
Net other financing activities
---1.31M
---1K
---906K
--0
---400K
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
26.81%238.35M
-10,300.00%-104K
-336.19%-916K
-100.01%-14K
29,151.33%239.38M
32.17%187.96M
-100.00%-1K
-100.22%-210K
--189M
-103.54%-824K
Net cash flow
Beginning cash position
-51.53%22.47M
63.62%34.55M
-65.17%35.62M
271.12%96.49M
-51.53%22.47M
-27.66%46.35M
12.12%21.12M
376.79%102.27M
-56.32%26M
-27.66%46.35M
Current changes in cash
285.05%44.19M
2,279.91%32.11M
98.69%-1.07M
-179.82%-60.88M
463.89%74.03M
-34.76%-23.88M
-95.10%1.35M
-3,002.26%-81.16M
300.34%76.27M
-347.61%-20.34M
End cash Position
196.71%66.66M
196.71%66.66M
63.62%34.55M
-65.17%35.62M
271.12%96.49M
-51.53%22.47M
-51.53%22.47M
12.12%21.12M
376.79%102.27M
-56.32%26M
Free cash flow
-10.74%-179.81M
56.55%-21.97M
-29.31%-53.93M
-27.54%-48.79M
-73.03%-55.13M
-80.05%-162.37M
-121.56%-50.55M
-114.48%-41.7M
-56.65%-38.26M
-35.60%-31.86M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -10.43%-178.78M57.48%-21.49M-28.83%-53.62M-27.34%-48.54M-74.39%-55.13M-82.21%-161.9M-134.35%-50.55M-114.10%-41.62M-56.08%-38.12M-34.98%-31.61M
Net income from continuing operations -13.15%-200.4M32.14%-33.77M-28.28%-64.81M-18.98%-53.43M-51.55%-48.4M-73.74%-177.12M-63.17%-49.76M-116.04%-50.53M-82.63%-44.9M-36.03%-31.93M
Depreciation and amortization -3.61%534K-14.97%125K-16.56%126K-3.47%139K28.57%144K29.74%554K42.72%147K39.81%151K34.58%144K2.75%112K
Other non cash items -19.14%2.66M-65.63%732K869.74%5.99M-1,696.70%-4.36M9.81%291K343.45%3.29M517.39%2.13M184.79%618K77.27%273K960.00%265K
Change In working capital 435.46%14.24M375.15%11.77M23.41%9.69M66.34%4.25M-230.45%-11.47M561.44%2.66M-182.16%-4.28M705.33%7.85M187.26%2.56M-21.75%-3.47M
-Change in receivables -150.81%-2.46M16.47%-578K-174.93%-275K-158.63%-1.09M-120.51%-516K-6,914.29%-982K-5,866.67%-692K6,216.67%367K-14,200.00%-423K-917.39%-234K
-Change in inventory 139.37%150K1,000.00%405K68.90%-51K58.72%-71K---133K---381K---45K---164K---172K--0
-Change in prepaid assets 120.63%598K325.52%2.17M-43.27%969K76.01%-666K-116.72%-1.88M-817.41%-2.9M-725.97%-964K551.91%1.71M-176.22%-2.78M-417.58%-867K
-Change in payables and accrued expense 129.33%14.8M443.93%9.13M45.12%8.87M2.52%5.91M-228.81%-9.11M8,392.11%6.45M-156.31%-2.65M654.69%6.11M369.52%5.77M16.26%-2.77M
-Change in other current assets 146.68%1.15M719.23%639K202.33%176K6.21%171K-58.50%166K-28.81%467K-76.15%78K-89.01%-172K-24.41%161K93.24%400K
Cash from discontinued investing activities
Operating cash flow -10.43%-178.78M57.48%-21.49M-28.83%-53.62M-27.34%-48.54M-74.39%-55.13M-82.21%-161.9M-134.35%-50.55M-114.10%-41.62M-56.08%-38.12M-34.98%-31.61M
Investing cash flow
Cash flow from continuing investing activities 69.21%-15.38M3.47%53.7M235.96%53.47M83.48%-12.32M-1,011.47%-110.22M29.73%-49.94M114.69%51.9M49.06%-39.33M-446.66%-74.61M374.34%12.09M
Net PPE purchase and sale -119.36%-1.03M---474K-269.88%-307K-79.86%-250K--064.56%-470K--0-1,975.00%-83K---139K-226.32%-248K
Net investment purchase and sale 71.00%-14.35M4.39%54.17M237.03%53.78M83.79%-12.07M-993.15%-110.22M29.07%-49.47M104.16%51.9M49.16%-39.24M-445.64%-74.47M384.88%12.34M
Cash from discontinued investing activities
Investing cash flow 69.21%-15.38M3.47%53.7M235.96%53.47M83.48%-12.32M-1,011.47%-110.22M29.73%-49.94M114.69%51.9M49.06%-39.33M-446.66%-74.61M374.34%12.09M
Financing cash flow
Cash flow from continuing financing activities 26.81%238.35M-10,300.00%-104K-336.19%-916K-100.01%-14K29,151.33%239.38M32.17%187.96M-100.00%-1K-100.22%-210K189M-103.54%-824K
Net issuance payments of debt --0--0--0--------2.24%49.96M-100.00%-1K100.40%1K--------
Net common stock issuance -101.25%-1.73M---89K--0-100.00%1K-99.27%-1.64M47.84%138M--0-100.22%-211K--139.03M4.63%-824K
Net preferred stock issuance --241.32M---78K---10K---15K--241.43M--0--0--0--0--0
Proceeds from stock option exercised by employees --64K------------------0----------------
Net other financing activities ---1.31M---1K---906K--0---400K--------------------
Cash from discontinued financing activities
Financing cash flow 26.81%238.35M-10,300.00%-104K-336.19%-916K-100.01%-14K29,151.33%239.38M32.17%187.96M-100.00%-1K-100.22%-210K--189M-103.54%-824K
Net cash flow
Beginning cash position -51.53%22.47M63.62%34.55M-65.17%35.62M271.12%96.49M-51.53%22.47M-27.66%46.35M12.12%21.12M376.79%102.27M-56.32%26M-27.66%46.35M
Current changes in cash 285.05%44.19M2,279.91%32.11M98.69%-1.07M-179.82%-60.88M463.89%74.03M-34.76%-23.88M-95.10%1.35M-3,002.26%-81.16M300.34%76.27M-347.61%-20.34M
End cash Position 196.71%66.66M196.71%66.66M63.62%34.55M-65.17%35.62M271.12%96.49M-51.53%22.47M-51.53%22.47M12.12%21.12M376.79%102.27M-56.32%26M
Free cash flow -10.74%-179.81M56.55%-21.97M-29.31%-53.93M-27.54%-48.79M-73.03%-55.13M-80.05%-162.37M-121.56%-50.55M-114.48%-41.7M-56.65%-38.26M-35.60%-31.86M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------
Trending Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.